The mortality rate due to pancreas malignant neoplasms in Japan is forecasted to increase steadily from 2024 to 2028, with values rising from 33.3 to 36.7 deaths per hundred thousand persons. Comparing this with the rate in 2023, an upward trend is expected, continuing the trend observed in prior years. The annual growth rate shows consistent increases, marking a growing health concern. Particularly, the percentage variation year-on-year underlines a gradual escalation in this mortality rate.

Future trends to watch:

Ongoing healthcare advancements and screening processes could potentially mitigate the rise in mortality rates.
Aging population dynamics in Japan will likely impact these rates, possibly accelerating them.
Public health policies and cancer treatment innovations are crucial to managing the future outcomes of this trend.